Suppr超能文献

肾移植后原发性小细胞癌:一例报告。

Primary small cell carcinoma after renal transplant: A case report.

作者信息

Wang Xueli, Wang Fenghua, Liang Yumei, Chen Wen

机构信息

Department of Pathology, The 8th Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

Medicine (Baltimore). 2018 Dec;97(49):e12592. doi: 10.1097/MD.0000000000012592.

Abstract

INTRODUCTION

Primary small cell carcinoma (SCC) after renal transplantation is very rare. Here, we reported 1 case of primary SCC after renal transplantation and analyzed its clinical and pathological characteristics.

CASE PRESENTATION

A 55-year-old female underwent renal transplantation in our hospital 2 years ago and had been using tacrolimus for immunosuppressive therapy. Because of abdominal distention, the patient was admitted to our hospital. Computed tomography (CT) showed a malignant tumor of left kidney. Patient underwent surgical treatment and radical nephrectomy and lymph node dissection were selected. Postoperative pathological diagnosis was primary renal parenchyma and ureteral SCC. The patient has been treated with combination chemotherapy of lowpol (100 mg per day) and etoposide (10 mg per day). His vital signs are stable now, and he is receiving further treatment in our hospital.

CONCLUSION

Because of immunosuppressive drugs use, the incidence of malignancies has increased significantly after renal transplantation. This case highlights the difficulty of diagnosis of primary SCC and the necessity of checking for neuroendocrine tumor after organ transplantation.

摘要

引言

肾移植后原发性小细胞癌(SCC)非常罕见。在此,我们报告1例肾移植后原发性SCC病例,并分析其临床和病理特征。

病例介绍

一名55岁女性2年前在我院接受肾移植,一直在使用他克莫司进行免疫抑制治疗。因腹胀入院。计算机断层扫描(CT)显示左肾恶性肿瘤。患者接受了手术治疗,选择了根治性肾切除术和淋巴结清扫术。术后病理诊断为原发性肾实质和输尿管SCC。患者接受了洛铂(每天100mg)和依托泊苷(每天10mg)的联合化疗。他目前生命体征稳定,正在我院接受进一步治疗。

结论

由于使用免疫抑制药物,肾移植后恶性肿瘤的发生率显著增加。该病例突出了原发性SCC诊断的困难以及器官移植后检查神经内分泌肿瘤的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbf5/6310489/1d65c00f707d/medi-97-e12592-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验